Valeant Announces Preliminary Resolution Of Allergan Shareholder Securities Litigation

December 29, 2017

Responsive image

Valeant Will Pay $96.25 Million to Resolve the Litigation
LAVAL, Quebec, Dec. 29, 2017 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (“Valeant” or the “Company”) today announced the parties in the cases of Basile v. Valeant Pharmaceuticals…

Category: Precious Metals